Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2475)
All Articles published online
|
May 7, 2005 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chang XM, Chang Y, Jia A. Effects of interferon-alpha on expression of hepatic stellate cell and transforming growth factor-β1 and α-smooth muscle actin in rats with hepatic fibrosis. World J Gastroenterol 2005; 11(17): 2634-2636 [PMID: 15849824 DOI: 10.3748/wjg.v11.i17.2634] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i17/2634.htm |
| Number | Citing Articles |
| 1 |
Montserrat Moreno, Ramon Bataller. Cytokines and Renin-Angiotensin System Signaling in Hepatic Fibrosis. Clinics in Liver Disease 2008; 12(4): 825 doi: 10.1016/j.cld.2008.07.013
|
| 2 |
Federico Tutau, Carlos Rodríguez‐Ortigosa, Juan Enrique Puche, Nerea Juanarena, Iñigo Monreal, María García Fernández, Encarna Clavijo, Alberto Castilla, Inma Castilla ‐ Cortázar. Enhanced actions of insulin‐like growth factor‐I and interferon‐α co‐administration in experimental cirrhosis. Liver International 2009; 29(1): 37 doi: 10.1111/j.1478-3231.2008.01770.x
|
| 3 |
Mio Kitano, P. Bloomston. Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis. Journal of Clinical Medicine 2016; 5(3): 38 doi: 10.3390/jcm5030038
|
| 4 |
Yan Huang, Ming-Hui Li, Min Hou, Yao Xie. Peginterferon alfa-2a for the treatment of chronic hepatitis C in the era of direct-acting antivirals. Hepatobiliary & Pancreatic Diseases International 2017; 16(5): 470 doi: 10.1016/S1499-3872(17)60044-4
|
| 5 |
Qinghua Li, Youcheng Ding, Xinlai Guo, Shenggen Luo, Huiren Zhuang, JingE Zhou, Nan Xu, Zhiqiang Yan. Chemically modified liposomes carrying TRAIL target activated hepatic stellate cells and ameliorate hepatic fibrosis in vitro and in vivo. Journal of Cellular and Molecular Medicine 2019; 23(3): 1951 doi: 10.1111/jcmm.14097
|
| 6 |
Ivan A. Akimov, Tatyana O. Kabilova, Valentin V. Vlassov, Elena L. Chernolovskaya. Inhibition of Human Cancer-Cell Proliferation by Long Double-Stranded RNAs. Oligonucleotides 2009; 19(1): 31 doi: 10.1089/oli.2008.0151
|
| 7 |
Tung-Hung Su, Jia-Horng Kao, Chun-Jen Liu. Molecular Mechanism and Treatment of Viral Hepatitis-Related Liver Fibrosis. International Journal of Molecular Sciences 2014; 15(6): 10578 doi: 10.3390/ijms150610578
|
| 8 |
Michelle Møhlenberg, Peter Lykke Eriksen, Tea Lund Laursen, Mette Bak Nielsen, Stephen Jacques Hamilton Dutoit, Henning Grønbæk, Rune Hartmann, Karen Louise Thomsen. The presence of interferon affects the progression of non-alcoholic fatty liver disease. Genes & Immunity 2022; 23(5): 157 doi: 10.1038/s41435-022-00176-6
|
| 9 |
Alexandre Vallée, Yves Lecarpentier, Rémy Guillevin, Jean-Noël Vallée. Interactions between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ in radiation-induced fibrosis. Oncotarget 2017; 8(52): 90579 doi: 10.18632/oncotarget.21234
|
| 10 |
Goran Šantak, Maja Šantak, Dubravko Forčić. Native Human IFN-αIs a More Potent Suppressor of HDF Response to Profibrotic Stimuli Than Recombinant Human IFN-α. Journal of Interferon & Cytokine Research 2007; 27(6): 481 doi: 10.1089/jir.2007.0174
|
| 11 |
M. Imaeda, H. Ishikawa, Y. Yoshida, T. Takahashi, Y. Ohkubo, A. Musha, M. Komachi, Y. Nakazato, T. Nakano. Long-term pathological and immunohistochemical features in the liver after intraoperative whole-liver irradiation in rats. Journal of Radiation Research 2014; 55(4): 665 doi: 10.1093/jrr/rru005
|
| 12 |
Young Kul Jung, Hyung Joon Yim. Reversal of liver cirrhosis: current evidence and expectations. The Korean Journal of Internal Medicine 2017; 32(2): 213 doi: 10.3904/kjim.2016.268
|
| 13 |
Nabil Mohie Abdel-Hamid, Ahmed Wahid, Maiiada Hassan Nazmy, Marwa Abdel-Moniem Eisa. Synergistic Effects of Jerusalem Artichoke in Combination with Pegylated Interferon Alfa-2a and Ribavirin Against Hepatic Fibrosis in Rats. Asian Pacific Journal of Cancer Prevention 2016; 17(4): 1979 doi: 10.7314/APJCP.2016.17.4.1979
|
| 14 |
Eduardo Lissen, Nathan Clumeck, Ricardo Sola, Maria Mendes-Correa, Julio Montaner, Mark Nelson, Jean DePamphilis, Mário Pessôa, Peter Buggisch, Janice Main, Douglas Dieterich. Histological response to pegIFNα-2a (40KD) plus ribavirin in HIV–hepatitis C virus co-infection. AIDS 2006; 20(17): 2175 doi: 10.1097/01.aids.0000247584.46567.64
|
| 15 |
Xinghang Dai, Yujun Zeng, Hu Zhang, Zhongwei Gu, Qiyong Gong, Kui Luo. Advances on Nanomedicines for Diagnosis and Theranostics of Hepatic Fibrosis. Advanced NanoBiomed Research 2021; 1(7) doi: 10.1002/anbr.202000091
|
| 16 |
Soula Danopoulos, Gail H. Deutsch, Claire Dumortier, Thomas J. Mariani, Denise Al Alam. Lung disease manifestations in Down syndrome. American Journal of Physiology-Lung Cellular and Molecular Physiology 2021; 321(5): L892 doi: 10.1152/ajplung.00434.2020
|
| 17 |
Yuki Minayoshi, Hitoshi Maeda, Keisuke Hamasaki, Taisei Nagasaki, Mei Takano, Ryo Fukuda, Yuki Mizuta, Motohiko Tanaka, Yutaka Sasaki, Masaki Otagiri, Hiroshi Watanabe, Toru Maruyama. Mouse Type-I Interferon-Mannosylated Albumin Fusion Protein for the Treatment of Chronic Hepatitis. Pharmaceuticals 2024; 17(2): 260 doi: 10.3390/ph17020260
|
| 18 |
Yumiko Sekiya, Tomohiro Ogawa, Masashi Iizuka, Katsutoshi Yoshizato, Kazuo Ikeda, Norifumi Kawada. Down‐regulation of cyclin E1 expression by microrna‐195 accounts for interferon‐β‐induced inhibition of hepatic stellate cell proliferation. Journal of Cellular Physiology 2011; 226(10): 2535 doi: 10.1002/jcp.22598
|